Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
T-Mobile US
TMUS
|
$576M |
| 2 |
AbbVie
ABBV
|
$478M |
| 3 |
Snap
SNAP
|
$318M |
| 4 |
Edwards Lifesciences
EW
|
$314M |
| 5 |
Boston Scientific
BSX
|
$284M |
Top Sells
| 1 |
Boeing
BA
|
$389M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$309M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$284M |
| 4 |
Shopify
SHOP
|
$240M |
| 5 |
Sysco
SYY
|
$217M |
Sector Composition
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
L3Harris
LHX
$51.9B
| $1.09B | 0.61% |
6,406,292
-692,385
| -10% | -$117M |
|
27
CoStar Group
CSGP
$37.9B
| $1.09B | 0.61% |
1,528,627
+101,148
| +7% | +$71.9M |
|
28
Abbott
ABT
$231B
| $1.07B | 0.6% |
11,720,454
+194,150
| +2% | +$17.8M |
|
29
Accenture
ACN
$162B
| $1.06B | 0.6% |
4,956,430
+1,011,351
| +26% | +$217M |
|
30
SS&C Technologies
SSNC
$21.7B
| $1.05B | 0.59% |
18,616,257
-335,529
| -2% | -$19M |
|
31
American Tower
AMT
$95.5B
| $1.04B | 0.58% |
4,015,816
-62,768
| -2% | -$16.2M |
|
|
32
T-Mobile US
TMUS
$284B
| $1.01B | 0.57% |
9,728,461
+5,529,047
| +132% | +$576M |
|
33
Fidelity National Information Services
FIS
$36.5B
| $997M | 0.56% |
7,437,618
-322,547
| -4% | -$43.2M |
|
34
Blackstone
BX
$134B
| $980M | 0.55% |
17,301,154
+419,358
| +2% | +$23.8M |
|
35
Thermo Fisher Scientific
TMO
$186B
| $965M | 0.54% |
2,664,549
+138,112
| +5% | +$50M |
|
36
Danaher
DHR
$147B
| $930M | 0.52% |
5,257,449
+76,639
| +1% | +$13.6M |
|
37
Eli Lilly
LLY
$659B
| $914M | 0.51% |
5,564,295
+786,253
| +16% | +$129M |
|
38
Progressive
PGR
$145B
| $901M | 0.51% |
11,244,244
+799,843
| +8% | +$64.1M |
|
39
Aon
AON
$79.1B
| $898M | 0.5% |
4,663,619
+126,657
| +3% | +$24.4M |
|
40
Nice
NICE
$8.73B
| $887M | 0.5% |
4,689,487
-444,390
| -9% | -$84.1M |
|
41
Broadridge
BR
$29.9B
| $836M | 0.47% |
6,623,688
+118,496
| +2% | +$15M |
|
42
Neurocrine Biosciences
NBIX
$13.8B
| $792M | 0.44% |
6,494,191
-1,135,008
| -15% | -$138M |
|
43
Humana
HUM
$36.5B
| $769M | 0.43% |
1,982,370
-108,906
| -5% | -$42.2M |
|
44
Intel
INTC
$106B
| $756M | 0.42% |
12,638,116
-335,134
| -3% | -$20.1M |
|
45
Alibaba
BABA
$330B
| $718M | 0.4% |
3,327,529
-150,442
| -4% | -$32.5M |
|
46
Walt Disney
DIS
$213B
| $717M | 0.4% |
6,434,121
-293,520
| -4% | -$32.7M |
|
47
Elanco Animal Health
ELAN
$9.12B
| $717M | 0.4% |
33,432,143
+2,643,285
| +9% | +$56.7M |
|
|
TMX
48
DELISTED
Terminix Global Holdings, Inc.
TMX
| $716M | 0.4% |
20,064,190
+749,542
| +4% | +$26.8M |
|
|
AVLR
49
DELISTED
Avalara, Inc.
AVLR
| $708M | 0.4% |
5,320,702
-1,073,209
| -17% | -$143M |
|
50
KLA
KLAC
$112B
| $699M | 0.39% |
3,591,765
-244,384
| -6% | -$47.5M |
|